{
  "_id": "80574574969b7b4aefac7aa74943c95a48384dcbdf4c5f0f4f97dbab583a259d",
  "feed": "wall-street-journal",
  "title": "Walgreens Posts Higher Sales, Powered by Covid-19 Vaccine, Testing Demand; The drugstore chain said it administered 11.8 million Covid-19 vaccinations in the latest quarter, which ended Feb. 28, and provided 6.6 million Covid-19 tests",
  "text": "<p>Walgreens Boots Alliance Inc. posted higher sales for its fiscal second quarter, as Covid-19 vaccinations and tests continued to boost business amid the surge of cases from the spread of the Omicron variant.</p><p>The Deerfield, Ill., drugstore chain said it administered 11.8 million Covid-19 vaccinations in the latest quarter, which ended Feb. 28, and provided 6.6 million Covid-19 tests, including over-the-counter at-home tests.</p><p>Covid-19-related demand led to higher costs in some parts of the business, Walgreens said. Adjusted selling, general and administrative expenses in the U.S. rose 8.3%, driven by investments to support vaccinations, testing and labor investments, it said.</p><p>Demand for Covid-19 tests, especially at-home kits, significantly outstripped supply at the start of the quarter as the fast-spreading Omicron variant spurred more people to seek diagnostic tools.</p><p>Demand for at-home Covid-19 tests helped drive a 43.3% increase in U.S. health and wellness sales. Comparable retail sales increased 14.7% in the U.S. compared with the year-ago period, the most in more than two decades, the company said.</p><p>U.S. prescriptions filled rose by 4.7% in the latest quarter on a comparable basis, largely driven by vaccinations. Excluding vaccinations, the increase was 1.8%.</p><p>Overall, Walgreens posted sales of $33.76 billion for the fiscal second quarter, up from $32.78 billion in the same period the year before. Analysts surveyed by FactSet were expecting sales of $33.23 billion.</p><p>The company posted net income attributable to Walgreens of $883 million, compared with $1.03 billion a year earlier. Earnings from continuing operations were $1.02 a share, compared with $1.06 a share in the year-ago period.</p><p>Adjusted for one-time items, earnings were $1.59 a share. Analysts surveyed by FactSet were looking for adjusted earnings of $1.37 a share.</p><p>Walgreens Posts Higher Sales, Powered by Covid-19 Vaccine, Testing Demand</p>",
  "published": "2022-03-31T11:56:00.000Z",
  "tags": [
    {
      "id": "US9314271084",
      "nexusId": "10022845",
      "name": "Walgreens Boots Alliance, Inc.",
      "offsets": [
        {
          "start": 0,
          "end": 29
        },
        {
          "start": 0,
          "end": 24
        }
      ]
    }
  ]
}